Haste makes waste. This adage can serve as a timely warning for the Drug Controller General of India which has notified the final rules — a draft version was issued last year — to guide clinical t...

The growth trajectory for the Indian pharmaceutical industry is likely to remain at 10-13 per cent in 2020-21 despite challenges, according to rating agency Icra.The expected growth in the next financ...

The government has sought inputs related to production, labour and logistics from clusters in five key sectors to ascertain expected output if they are made operational within a fortnight and procedur...

Ramesh Swaminathan, chief financial officer (CFO) of Lupin, is stepping down from the pharmaceutical firm.On Tuesday, Lupin informed bourses that Swaminathan has decided to pursue responsibilities out...

The prices of key pharmaceutical ingredients could rise if the coronavirus situation in China does not improve soon, a top company official said on Tuesday. “The prices of active pharmaceutical ing...

Drug majors Aurobindo Pharma and Dr Reddy’s Laboratories on Tuesday said they were preparing their legal defence to the charges of price fixing in the US market.As many as 49 US states have filed pr...